rs41307640
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_031407.7(HUWE1):āc.1448A>Gā(p.Asn483Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0236 in 1,197,201 control chromosomes in the GnomAD database, including 320 homozygotes. There are 8,633 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_031407.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HUWE1 | NM_031407.7 | c.1448A>G | p.Asn483Ser | missense_variant | 17/84 | ENST00000262854.11 | NP_113584.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HUWE1 | ENST00000262854.11 | c.1448A>G | p.Asn483Ser | missense_variant | 17/84 | 1 | NM_031407.7 | ENSP00000262854 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0187 AC: 2068AN: 110497Hom.: 26 Cov.: 22 AF XY: 0.0173 AC XY: 566AN XY: 32719
GnomAD3 exomes AF: 0.0177 AC: 3236AN: 182765Hom.: 36 AF XY: 0.0171 AC XY: 1151AN XY: 67239
GnomAD4 exome AF: 0.0241 AC: 26137AN: 1086659Hom.: 294 Cov.: 26 AF XY: 0.0228 AC XY: 8068AN XY: 353459
GnomAD4 genome AF: 0.0187 AC: 2067AN: 110542Hom.: 26 Cov.: 22 AF XY: 0.0172 AC XY: 565AN XY: 32774
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 19, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 08, 2013 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at